Peritoneal dialysis is the most common treatment for end-stage renal disease. However, peritoneal fibrosis resulting from long-term peritoneal dialysis restricts peritoneal ultrafiltration. Previous studies have shown a role for 1,25-dihydroxyvitamin D3 (1,25[OH] 2 D3) in preventing fibrosis, but the potential mechanisms remain unknown. This study aimed to investigate the role of 1,25(OH) 2 D3 in epithelial-mesenchymal transition (EMT) and the downstream signaling pathway in HMrSV5 human peritoneal mesothelial cells in vitro.
Background
Worldwide, end-stage renal disease leading to kidney failure has become an important public health concern. In 2010, it has been reported that in China there were more than 100,000 patients suffering from end-stage renal disease treated with peritoneal dialysis or maintenance hemodialysis [1] . Peritoneal dialysis is the most widely used treatment for end-stage renal disease. However, the chronic exposure of the peritoneal membrane to the peritoneal dialysis solution during longterm peritoneal dialysis can result in several complications [2] . Peritoneal fibrosis can occur in patients undergoing peritoneal dialysis and is also one of the reasons for patients with endstage renal disease to withdraw from peritoneal dialysis treatment [3] . Therefore, it is important to investigate the underlying mechanisms of peritoneal fibrosis.
Peritoneal fibrosis is accompanied by loss of the mesothelial cell layer and proliferation of cells in the submesothelial layer [4, 5] . The morphological changes in the peritoneal membrane ultimately lead to changes in the submesothelial subcompact zone and blood vessels, which results in failure of ultrafiltration [6, 7] . Previous studies have shown that epithelial-mesenchymal transition (EMT) of peritoneal mesothelial cells is one of the key factors contributing to the development of peritoneal fibrosis [8, 9] . Although novel types of peritoneal dialysis solutions and anti-fibrotic agents have been developed, their therapeutic effects on peritoneal fibrosis have remained unsatisfactory due to the characteristics of the fluid composition that includes high glucose, low pH, increased lactate concentration and osmolality, and the presence of glucose degradation products [10, 11] . The mechanisms of anti-fibrotic drugs, including tamoxifen, remain unknown [12] . Therefore, the mechanisms associated with peritoneal fibrosis require further study.
1,25-dihydroxyvitamin D3 (1,25[OH] 2 D3) is the bioactive metabolite of vitamin D, which plays a crucial role in many biological mechanisms through binding the vitamin D receptor (VDR).
Early studies demonstrated the key roles of 1,25(OH) 2 D3 in calcium homeostasis, cell proliferation and cell differentiation [13] . Recent studies have also indicated the regulatory functions of 1,25(OH) 2 D3 in inflammation and fibrosis [14, 15] . Vitamin D insufficiency is common among patients with chronic kidney disease, as a reduced glomerular filtration rate (GFR) can result in decreased production of 1,25(OH) 2 D3 [16, 17] . Treatment with 1,25(OH) 2 D3 has been shown to significantly reduce the development of fibrotic lesions in experimental models of chronic kidney diseases [18] . Both of in vivo and in vitro studies have also shown the role of 1,25(OH) 2 D3 in inhibiting the process of epithelial-mesenchymal transition (EMT) in renal interstitial fibrosis [18] . Also, 1,25(OH) 2 D3 has been shown to reverse the reduced cell viability and apoptosis of mesothelial cells, which was correlated with the duration of peritoneal dialysis in the peritoneum in a rat model [19] . Therefore, further studies are needed to determine the role of 1,25(OH) 2 D3 in the prevention of the progression of peritoneal fibrosis.
The regulatory role of histone deacetylases (HDACs) in the development of fibrosis has been shown in several disease models, including cardiac fibrosis, the activity of hepatic stellate cells or hepatic pericytes, and renal fibroblasts [20, 21] . HDACs are enzymes that catalyze the removal of acetyl groups from lysine residues in histones and proteins and are associated with decreased proliferation and morphological changes of fibroblasts induced by TGF-b signaling [22] . However, whether there is a correlation between 1,25(OH) 2 D3 and HDACs remains unknown.
Therefore, this study aimed to investigate the role of 1,25(OH) 2 D3 in EMT and the downstream signaling pathway in HMrSV5 human peritoneal mesothelial cells in vitro. The study also aimed to investigate the regulatory signaling network of 1,25(OH) 2 D3 on HDAC3 and VDR through Wnt/bcatenin signaling pathway.
Material and Methods

Cell culture and treatment
Human peritoneal mesothelial cell line HMrSV5 was purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). HMrSV5 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco, Thermofisher Scientific, Waltham, MA, USA) with adding 10% fetal bovine serum (FBS) (Gibco, Thermofisher Scientific, Waltham, MA, USA), 100 ul/ml streptomycin and 100 U/ml penicillin (Life Technologies, Carlsbad, CA, USA). The cells were incubated at 37°C humidified atmosphere with 5% CO 2 until 50-70% confluence before used. Cells were transferred to serum-free DMEM medium 12 h prior to each experiment. Cells in the control group were maintained in serumfree DMEM medium. For the experimental groups, HMrSV5 cells were treated with high glucose (25 μM) and lipopolysaccharide (LPS0, 910 μg/ml) for 24 h. As for the role of 1,25(OH) 2 D3, HMrSV5 cells were pre-incubated with 1,25(OH) 2 D3 (10 -6 mol/L) for 2 h and subsequently treated with high glucose (25 μM) and LPS (10 μg/ml) for 24 h. Wnt agonist 1, 0.7 μM for 12 h (MedChem Express, Monmouth Junction, NJ, USA) was also used, as previously described [23] . Glucose, LPS, and 1,25(OH) 2 D3 were purchased from Sigma-Aldrich (St. Louis, MO, USA). The concentrations of glucose and LPS were determined from the findings of preliminary experiments.
MTT assay
To determine the optimized concentrations of glucose and LPS used in the subsequent experiments, HMrSV5 cells were seeded in 96-well plate and cultured after exposure to solutions containing gradients of glucose and LPS (glucose: 0, 10, 25, 40, 65, 80 μM; LPS: 0, 1, 5, 10, 20, 30 μg/ml). Cells were then incubated with 50 μg/ml MTT at a dilution of 1: 10 for 3 h at 37°C. At the end of treatment, the MTT solution was removed and 150 μl of dimethyl sulfoxide (DMSO) was added to each well. The dark-blue formazan crystals that formed in each well were stirred to until they dissolved. The proportion of viable cells was measured at a wavelength of 450 nm with a spectrophotometer. The experiments were performed in triplicate and the mean values of each group of cultures were compared.
Cell Counting Kit-8 (CCK-8) cell proliferation assay
The proliferation of HMrSV5 cells was assessed with Cell Counting Kit-8 (CCK-8) assay (Vazyme Biotech Co., Nanjing, China), according to the manufacturer's instructions. HMrSV5 cells were seeded into a 96-well plate incubated with high glucose plus LPS for the indicated times. An enzyme-linked immunosorbent assay (ELISA) plate reader was used to measure the absorbance at 490 nm. Each experiment was performed in triplicate.
Flow cytometry
Cells were obtained after centrifugation for 5 min at 500×g at 4°C, and then resuspended to 1×10 6 cells/ml. An apoptosis detection kit (Nanjing KeyGen Biotech, Nanjing, China) was used, according to the manufacturer's instructions and measurements were performed using a FACSCalibur flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). All data were analyzed with BD FACSDiva software (BD Biosciences, Franklin Lakes, NJ, USA).
Cell transfection
The short-hairpin RNA (shRNA) sequences targeting human VDR and HDAC3 genes were obtained from GenePharma (Shanghai, China) and were transfected into cells with Lipofectamine 2000 (Life Technologies, USA), according to the manufacturer's instructions. For HDAC3 gene overexpression, transfection was performed with 2 μg of the plasmid into HMrSV5 cells. Wnt agonist 1, a Wnt signaling pathway activator, was used (MedChem Express, Monmouth Junction, NJ, USA).
RNA extraction, reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted using TRIzol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions and diluted to 200 ng/ml. The mRNA levels were measured by quantitative real-time polymerase chain reaction (qRT-PCR), which was performed using OneStep SYBR ® PrimeScript™ RT-PCR Kit II (Takara, Minato-ku, Tokyo, Japan) according to manufacturer's protocol. The relative gene expression was calculated using the 2 -DDCt method. GAPDH was used as an internal control. Primers used in qRT-PCR were as follows: VDR: Forward: 5'-GCCCACCACAAGACCTA-3'. Reverse: 5'-CCTTTTGGATGCTGTAACTG-3'. GAPDH: Forward: 5'-GGACCAATACGACCAAATCCG-3'. Reverse: 5'-AGCCACATCGCTCAGACAC-3'.
Western blot
Cells were harvested and homogenized with cell lysis buffer (Beyotime, Shanghai, China) on ice for 30 min. Lysed cells were centrifuged for 30 min at 4°C and the supernatants were taken. The total protein was measured using the Bradford method. An equal amount of protein samples was separated by denaturing 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto a polyvinylidene difluoride (PVDF) membrane. The PVDF membrane was blocked in 5% dried skimmed milk powder in TBST solution at room temperature for 1 h. The membrane was then washed and incubated at 4°C overnight with specific primary antibodies to: histone deacetylase 3 (HDAC3) (1: 300) (Santa Cruz Biotechnology Inc., Dallas, TX, USA), vitamin D receptor (VDR) (1: 1000) (Cell Signaling Technology, Danvers, MA, USA), b-catenin (1: 1000) (Cell Signaling Technology, Danvers, MA, USA), E-cadherin (1: 1000) (Abcam, Cambridge, MA, USA), N-cadherin (1: 1000, BD, USA), a-smooth muscle actin (a-SMA) (1: 1000) (Abcam, Cambridge, MA, USA), type I collagen (1: 1500) (Abcam, Cambridge, MA, USA), fibronectin (1: 2000) (Abcam, Cambridge, MA, USA), and b-actin (1: 1000) (Sigma-Aldrich, St. Louis MO, USA). The membrane was incubated in the secondary antibodies conjugated with horseradish peroxidase (HRP) (1: 1000) (Bio-Rad, Hercules, CA, USA) at room temperature for 2 h. Protein bands were visualized using an enhanced chemiluminescence (ECL) Western blotting detection system (GE Healthcare Life Sciences, Logan, UT, USA) according to the manufacturer's instruction. The intensity of each band was measured using ImageJ software (National Institutes of Health, Bethesda, MD, USA).
Statistical analysis
All data were expressed as the mean ± standard deviation (SD). Statistical significance was determined by Student's t-test. Multiple groups were analyzed using analysis of variance (ANOVA). A P-value <0.05 was considered to be significant. 
Results
Culture medium containing high glucose and lipopolysaccharide (LPS) induced apoptosis and epithelialmesenchymal transition (EMT) of HMrSV5 human peritoneal mesothelial cells HMrSV5 cells were exposed to increasing concentrations of glucose and lipopolysaccharide (LPS). The findings of the MTT assay were used to determine the optimal concentration levels for the subsequent experiments. As shown in Figure 1A and 1B, the optimal concentration of glucose was between 25-40 μM, while the optimal concentration of LPS was between 10-20 μg/ml. The final concentration of glucose (25 μM) and LPS (10 μg/ml) were determined and used in subsequent experiments.
The Cell Counting Kit-8 (CCK-8) assay was also performed to determine the effects of high glucose plus LPS on the inhibition of cell growth, and the results showed that high glucose combined with LPS significantly reduced cell viability when compared with the controls ( Figure 1C ). Flow cytometry showed that the apoptotic cell rate was also significantly increased in HMrSV5 cells stimulating with high glucose plus LPS ( Figure 1D ), A variety of morphological features of HMrSV5 mesothelial cells were observed ( Figure 1E) , with a trend towards fibroblast-like cell differentiation in the high glucose plus LPS group when compared with the control group. Western blot showed that the expression levels of the EMT-associated biomarker E-cadherin were significantly decreased, while the expression of b-catenin, N-cadherin, a-SMA, collagen I, and fibronectin were significantly increased in high glucose plus LPS treated cells when compared with the controls ( Figure 1F ). These data suggested that culture medium containing high glucose combined with LPS could induce apoptosis and EMT, which are changes associated with peritoneal fibrosis seen in vivo.
The effects of 1,25(OH) 2 D3 on cell apoptosis and EMT by high glucose plus LPS To further investigate the role of 1,25(OH) 2 D3 in apoptosis and EMT, the HMrSV5 cells were pre-incubated with 1,25(OH) 2 D3 before exposure to high glucose plus LPS. The Cell Counting Kit-8 (CCK-8) assay was performed to assess the cell proliferation and showed that high glucose plus LPS significantly inhibited cell proliferation, which was reversed by 1,25(OH) 2 D3 (Figure 2A ).
Flow cytometry showed that the increase in apoptosis induced by high glucose plus LPS was also significantly reduced in the presence of 1,25(OH) 2 D3 ( Figure 2B) . Also, cells exposed to high glucose plus LPS showed a trend for the morphological change to fibroblast-like cells, but 1,25(OH) 2 D3 converted the morphology of HMrSV5 to more typical mesothelial cells with a cobblestone-like growth pattern, which was similar to that in control group ( Figure 2C ). Western blot analysis also showed that the protein expression levels of the EMT-associated biomarker E-cadherin was significantly increased and other biomarkers, including b-catenin, N-cadherin, a-SMA, collagen I, and fibronectin were reduced in the presence of 1,25(OH) 2 D3 ( Figure 2D ). These findings indicated that 1,25(OH) 2 D3 may have a protective role to prevent the inhibition of cell growth and the process of EMT stimulated by high glucose combined with LPS.
1,25(OH) 2 D3 regulated EMT by inhibiting HDAC3 and upregulating VDR expression
To further explore the underlying mechanism responsible for regulatory functions of 1,25(OH) 2 D3 on the process of EMT, quantitative real-time polymerase chain reaction (qRT-PCR) and w estern blot were performed to detect the expression pattern of HDAC3 and VDR genes and protein in HMrSV5 cells exposed to high glucose plus LPS in the presence or absence of 1,25(OH) 2 D3. HDAC3 was significantly upregulated when HMrSV5 cells were exposed to high glucose plus LPS, while this effect was reversed with 1,25(OH) 2 D3 ( Figure 3A, 3B) . The expression of VDR was down-regulated when HMrSV5 cells were cultured in media containing high glucose plus LPS, but VDR expression increased in the presence of 1,25(OH) 2 D3 ( Figure 3C, 3D ).
Based on the findings from previous studies, a short-hairpin RNA (shRNA) plasmid was used to specifically target VDR and HDAC3 to induce overexpression and used for cell transfection. Western blot showed that the expression of the EMT-associated biomarker E-cadherin was increased and the expression levels of other biomarkers, b-catenin, N-cadherin, a-SMA, collagen I, and fibronectin, were reduced in the absence of 1,25(OH) 2 D3. Knockdown of VDR or overexpression of HDAC3 both blocked the effects of 1,25(OH) 2 D3 ( Figure 3E ). These data suggested that 1,25(OH) 2 D3 might prevent EMT in mesothelial cells by modifying VDR and HDAC3 expression.
HDAC3 negatively regulated VDR expression
To further explore the relationship between HDAC3 and VDR in cells cultured in high levels of glucose with LPS, or with treatment with 1,25(OH) 2 D3, knockdown of HDAC3 by shRNA was used. As shown in Figure 4A , 4B, the mRNA and protein levels of VDR were significantly down-regulated or upregulated in cells transfected with HDAC3 or shHDAC3, compared with the control group. Analysis of cell apoptosis, detected using the flow cytometry, showed that the increased apoptotic cell rate induced by high glucose plus LPS was significantly reduced by HDAC3 knockdown or VDR overexpression ( Figure 4C, 4D) . with Wnt agonist 1 ( Figure 5A ). Western blot showed that the regulatory effects of 1,25(OH) 2 D3 on the down-regulation of HDAC3 and the upregulation of VDR were also reversed by Wnt agonist 1 ( Figure 5B ).
EMT-associated biomarkers were also measured. As shown in Figure 5C 
